<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The bone marrow is the major site of haemopoiesis in adult human </plain></SENT>
<SENT sid="1" pm="."><plain>It contains cells that represent the stages in the development of different types of blood cells e.g. myelocytes, metamyelocytes, erythroblasts, reticulocytes, and other lymphoid progenies etc </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0005528'>Bone marrow failure</z:hpo> is primarily the result of a specific failure of bone marrow precursor cells to produce mature cells </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="23995">N-ethyl N-nitroso urea</z:chebi> (<z:chebi fb="0" ids="23995">ENU</z:chebi>) is one of the most potent <z:chebi fb="1" ids="25435">mutagens</z:chebi> that can create an abnormal bone marrow microenvironment by causing defect in haematopoietic stem cell maturation cascade </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="23995">ENU</z:chebi> is easy to administer in mouse, and some probable mutations can be helpful to create models of human diseased conditions like <z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is considered as an intravascular <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e>, a combined structural-functional abnormality wherein the differentiation procedure of the bone marrow stem cell is either incomplete or defective </plain></SENT>
<SENT sid="6" pm="."><plain>We assumed that <z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> stands in between an inhibitory cellular pattern and a positive overshoot of abnormal differentiations representing an unknown juncture where the mystery of <z:mpath ids='MPATH_58'>aplasia</z:mpath> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> hide back </plain></SENT>
<SENT sid="7" pm="."><plain>Instead of using a transgenic mouse model, we attempted to develop an experimentally induced murine model of <z:e sem="disease" ids="C0026986,C0033027" disease_type="Neoplastic Process" abbrv="">preleukemia</z:e> or human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> like <z:e sem="disease" ids="C0684309" disease_type="Experimental Model of Disease" abbrv="">disease model</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In doing so <z:chebi fb="0" ids="23995">ENU</z:chebi> has been administered i.p and the animals were examined on thirtieth day and peripheral blood haemogram was documented </plain></SENT>
<SENT sid="9" pm="."><plain>Upon registering the appearance of abnormal peripheral blood scenario, the changes in the intravascular bone marrow (BM) architecture, cell surface receptor expression, e.g. Sca-1, c-Kit and the early and late phase apoptic patterns were noted </plain></SENT>
<SENT sid="10" pm="."><plain>The results represented an interesting correlation in between bone marrow architecture, early stem cell receptor and apoptic marker expression resembling human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>